Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

MNPRMNPR
6 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in MONOPAR THERAPEUTICS INC

NORTHERN TRUST CORP holds 34,641 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $3.2M as of 2026-Q2. The position was increased (+8.7% shares). MNPR represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$3.2M

Current Shares

34,641

Total Value Change

+$2.9M

Total Shares Change

+25,480

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
34,641
+8.7%
$3.2M0.0%$92.59
29
2026-Q1
Increased
31,862
+4.5%
$1.7M0.0%$51.88
27
2025-Q4
Increased
30,488
+13.5%
$2M0.0%$65.07
29
2025-Q3
Decreased
26,855
-15.6%
$2.2M0.0%$75.90
0
2025-Q2
Increased
31,813
+247.3%
$1.1M0.0%$33.60
41
2025-Q1
New
9,161
-
$333,5520.0%$40.33
36

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used